BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32253675)

  • 21. NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis.
    Malczewska A; Oberg K; Kos-Kudla B
    Endocr Connect; 2021 Jan; 10(1):110-123. PubMed ID: 33289691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study.
    van Treijen MJC; Korse CM; van Leeuwaarde RS; Saveur LJ; Vriens MR; Verbeek WHM; Tesselaar MET; Valk GD
    Front Endocrinol (Lausanne); 2018; 9():740. PubMed ID: 30564197
    [No Abstract]   [Full Text] [Related]  

  • 23. The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK.
    Malczewska A; Procner A; Walter A; Kusnierz K; Zajecki W; Aslanian H; Kos-Kudla B
    BMC Gastroenterol; 2020 Jul; 20(1):235. PubMed ID: 32703157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood mRNA Measurement (NETest) for Neuroendocrine Tumor Diagnosis of Image-Negative Liver Metastatic Disease.
    Malczewska A; Bodei L; Kidd M; Modlin IM
    J Clin Endocrinol Metab; 2019 Mar; 104(3):867-872. PubMed ID: 30358858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical utility of circulating neuroendocrine gene transcript analysis in well-differentiated paragangliomas and pheochromocytomas.
    Pęczkowska M; Cwikla J; Kidd M; Lewczuk A; Kolasinska-Ćwikła A; Niec D; Michałowska I; Prejbisz A; Januszewicz A; Chiarelli J; Bodei L; Modlin I
    Eur J Endocrinol; 2017 Feb; 176(2):143-157. PubMed ID: 27913608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine Tumor Omic Gene Cluster Analysis Amplifies the Prognostic Accuracy of the NETest.
    Kidd M; Kitz A; Drozdov I; Modlin I
    Neuroendocrinology; 2021; 111(5):490-504. PubMed ID: 32392558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NETest: The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine Tumors.
    Modlin IM; Kidd M; Malczewska A; Drozdov I; Bodei L; Matar S; Chung KM
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):485-504. PubMed ID: 30098712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NETest: A Systematic Review Focusing on the Prognostic and Predictive Role.
    Puliani G; Di Vito V; Feola T; Sesti F; Centello R; Pandozzi C; Tarsitano MG; Verrico M; Lenzi A; Isidori AM; Giannetta E; Faggiano A
    Neuroendocrinology; 2022; 112(6):523-536. PubMed ID: 34515175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASO Author Reflections: Circulating Neuroendocrine Gene Transcripts (NETest): A Promising Biomarker for Pancreatic Neuroendocrine Tumours (PanNET).
    Partelli S; Falconi M
    Ann Surg Oncol; 2020 Oct; 27(10):3937-3938. PubMed ID: 32462530
    [No Abstract]   [Full Text] [Related]  

  • 30. Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors.
    Pulvirenti A; Rao D; Mcintyre CA; Gonen M; Tang LH; Klimstra DS; Fleisher M; Ramanathan LV; Reidy-Lagunes D; Allen PJ
    HPB (Oxford); 2019 May; 21(5):612-618. PubMed ID: 30366884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromogranin A predicts survival for resected pancreatic neuroendocrine tumors.
    Shanahan MA; Salem A; Fisher A; Cho CS; Leverson G; Winslow ER; Weber SM
    J Surg Res; 2016 Mar; 201(1):38-43. PubMed ID: 26850182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity and Specificity of the NETest: A Validation Study.
    Al-Toubah T; Cives M; Valone T; Blue K; Strosberg J
    Neuroendocrinology; 2021; 111(6):580-585. PubMed ID: 32615553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.
    Liu E; Paulson S; Gulati A; Freudman J; Grosh W; Kafer S; Wickremesinghe PC; Salem RR; Bodei L
    Oncologist; 2019 Jun; 24(6):783-790. PubMed ID: 30158287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standard pre- and postoperative determination of chromogranin a in resectable non-functioning pancreatic neuroendocrine tumors--diagnostic accuracy: NF-pNET and low tumor burden.
    Jilesen AP; Busch OR; van Gulik TM; Gouma DJ; Nieveen van Dijkum EJ
    Dig Surg; 2014; 31(6):407-14. PubMed ID: 25572908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis.
    Malczewska A; Kidd M; Matar S; Kos-Kudła B; Bodei L; Oberg K; Modlin IM
    Neuroendocrinology; 2020; 110(3-4):198-216. PubMed ID: 31266019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between preoperative Vasostatin-1 and pathological features of aggressiveness in localized nonfunctioning pancreatic neuroendocrine tumors (NF-PanNET).
    Andreasi V; Partelli S; Manzoni M; Muffatti F; Colombo B; Corti A; Falconi M
    Pancreatology; 2019 Jan; 19(1):57-63. PubMed ID: 30470614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.
    Qiao XW; Qiu L; Chen YJ; Meng CT; Sun Z; Bai CM; Zhao DC; Zhang TP; Zhao YP; Song YL; Wang YH; Chen J; Lu CM
    BMC Endocr Disord; 2014 Aug; 14():64. PubMed ID: 25099181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood.
    Öberg K; Califano A; Strosberg JR; Ma S; Pape U; Bodei L; Kaltsas G; Toumpanakis C; Goldenring JR; Frilling A; Paulson S
    Ann Oncol; 2020 Feb; 31(2):202-212. PubMed ID: 31959337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
    Corsello A; Di Filippo L; Massironi S; Sileo F; Dolcetta Capuzzo A; Gemma M; Carlucci C; Cusini C; Colombo B; Dallatomasina A; Franchi GM; Corti A; Manzoni MF
    PLoS One; 2018; 13(5):e0196858. PubMed ID: 29723285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status.
    Bodei L; Kidd M; Modlin IM; Prasad V; Severi S; Ambrosini V; Kwekkeboom DJ; Krenning EP; Baum RP; Paganelli G; Drozdov I
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1341-52. PubMed ID: 25947577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.